Oxcarbazepine for the Treatment of Chronic Peripheral Neuropathic Pain

PHASE4CompletedINTERVENTIONAL
Enrollment

117

Participants

Timeline

Start Date

February 28, 2011

Primary Completion Date

May 31, 2013

Study Completion Date

May 31, 2013

Conditions
PolyneuropathyPeripheral Nerve InjuryPostherpetic Neuralgia
Interventions
DRUG

Oxcarbazepine

Oxcarbazepine capsules 300 mg is gradually increased from 300 mg/day to 2400 mg/day Placebo capsules increase from 1/day to 8/day

Trial Locations (2)

8000

Danish Pain Research Center, Aarhus University Hospital, Aarhus

DK-5000

Department of Neurology, Odense University Hospital, Odense

Sponsors
All Listed Sponsors
collaborator

Danish Pain Research Center

OTHER

collaborator

Innovative Medicines Initiative

OTHER

lead

Søren H. Sindrup

OTHER